Premium
Target Identification of a 1,3,4‐Oxadiazin‐5(6 H )‐One Anticancer Agent via Photoaffinity Labelling
Author(s) -
Lim Bumhee,
Lee Jinah,
Kim Byungjin,
Lee Rang,
Park Jaehyun,
Oh DongChan,
Gam Jongsik,
Lee Jeeyeon
Publication year - 2019
Publication title -
asian journal of organic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.846
H-Index - 44
eISSN - 2193-5815
pISSN - 2193-5807
DOI - 10.1002/ajoc.201900258
Subject(s) - labelling , chemistry , hela , photoaffinity labeling , proteome , in vitro , biochemistry , a549 cell , cell culture , affinity label , receptor , biology , genetics
Rational design and synthetic feasibility are critical factors for the photoaffinity labelling (PAL) approach, which can identify protein targets of bioactive small molecules under native cellular conditions. In this study, we developed photoaffinity labelling probes derived from 1,3,4‐oxadiazin‐5(6 H )‐ones ( OPALs ) for LL‐2003, a previously reported potential anticancer agent against IGF‐1R and Src. Our photoaffinity labelling strategy enabled successful photo‐crosslinking of the probes ( OPAL‐6 and OPAL‐8 ) with the target proteins in both mammalian cell lysates and live MCF7, A549, HepG2 and HeLa cells in situ . In vitro and in situ labelling demonstrated different patterns and expression levels of the proteome, and the strongest band for Src appeared in the A549 cell line. An in‐gel fluorescence scan combined with MS/MS analysis of the IGF‐1R overexpressed insect proteome labelled by OPAL‐6 and OPAL‐8 identified the binding location of the synthesized probes.